MARLBOROUGH, Massachusetts, Jan. 3, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the MyoSure ® MANUAL device, which was designed to simplify tissue removal procedures ...

During a live surgical webcast originating at Springhill Medical Center, gynecologic surgeons from all over the world will have the unique opportunity to view a hysteroscopic myomectomy, featuring the ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today the U.S. launch of its Omni™ hysteroscope, an innovative three-in-one modular scope with advanced visualization ...

Hologic, Inc. HOLX recently announced the launch of new Fluent fluid management system in the United States. Per the company, this system is embedded with features that simplify and improvise the ...

Interlace Medical Inc. reports it has received clearance from the U.S. Food and Drug Administration for a process for a gynecological treatment. Framingham-based Interlace received 510K clearance from ...

Doha: Al-Ahli Hospital uses modern technology to remove fibroids, benign tumors, and other tissues without removing the uterus. Dr. Mazen Bishtawi, obstetrician and gynecologist consultant, said: “The ...

Hologic, one of the few companies to emerge from the pandemic stronger than it was before, has scored regulatory approvals in Canada and Europe for an updated version of its NovaSure V5 endometrial ...